President and CEO Charles Briscoe will step down after the completion of the Houston Healthcare and Emory Healthcare merger. He served as CEO for eight years.

Two individuals from JD(U) in Bihar resigned over disagreements with the party's support for the Waqf (Amendment) Bill, which ...

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and ...